SUSANNA HALL: Open Payments
NPI 1487988150 · TUSCUMBIA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$742 in 38 payments from 9 companies in 2025. Trend: 2023 $411 · 2024 $621 · 2025 $742
Food & beverage: $742
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $446 |
| PFIZER INC. | 3 | $53 |
| ABBVIE INC. | 3 | $47 |
| AstraZeneca Pharmaceuticals LP | 3 | $45 |
| Lundbeck LLC | 2 | $38 |
| Phathom Pharmaceuticals, Inc. | 3 | $35 |
| Dexcom, Inc. | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $29 |
| Amgen Inc. | 1 | $14 |
Products named: Ozempic, Wegovy, VYEPTI, PREVNAR 20, VOQUEZNA, Dexcom G6 Transmitter, VRAYLAR, CAPLYTA.
Industry payments across AL — which companies pay providers there.
